1. Home
  2. SGMO vs GRX Comparison

SGMO vs GRX Comparison

Compare SGMO & GRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sangamo Therapeutics Inc.

SGMO

Sangamo Therapeutics Inc.

HOLD

Current Price

$0.39

Market Cap

135.1M

Sector

Health Care

ML Signal

HOLD

Logo The Gabelli Healthcare & Wellness Trust of Beneficial Interest

GRX

The Gabelli Healthcare & Wellness Trust of Beneficial Interest

HOLD

Current Price

$9.64

Market Cap

147.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGMO
GRX
Founded
1995
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
135.1M
147.2M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
SGMO
GRX
Price
$0.39
$9.64
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$5.60
N/A
AVG Volume (30 Days)
4.3M
39.7K
Earning Date
11-06-2025
01-01-0001
Dividend Yield
N/A
5.98%
EPS Growth
N/A
N/A
EPS
N/A
0.26
Revenue
$32,875,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$38.50
Revenue Growth
N/A
N/A
52 Week Low
$0.37
$7.73
52 Week High
$1.40
$10.40

Technical Indicators

Market Signals
Indicator
SGMO
GRX
Relative Strength Index (RSI) 41.13 52.36
Support Level $0.37 $9.58
Resistance Level $0.48 $9.71
Average True Range (ATR) 0.03 0.10
MACD -0.00 -0.00
Stochastic Oscillator 30.36 52.17

Price Performance

Historical Comparison
SGMO
GRX

About SGMO Sangamo Therapeutics Inc.

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

About GRX The Gabelli Healthcare & Wellness Trust of Beneficial Interest

Gabelli Healthcare & WellnessRx Trust operates as a diversified closed-end management investment company. The investment objective of the fund is the long-term growth of capital. The fund invests at least its assets in equity securities and income-producing securities of domestic and foreign companies in the healthcare and wellness industries. It invests in various sectors, of which Health Care Providers & Services, Food, Health Care Equipment and Supplies, and Pharmaceuticals account for the majority of the weightage.

Share on Social Networks: